National HIV Curriculum Podcast
This podcast series explores practice-changing issues and updates in HIV diagnosis, management, and prevention through Case Discussions, Expert Interviews, Literature Reviews, and Conference Summaries. The three podcast hosts include Lead Editor Dr. Brian Wood, Professor of Medicine at the University of Washington (UW), Editor Dr. Jehan Budak, UW Assistant Professor of Medicine, and Editor Dr. Aley Kalapila, Professor of Medicine, Emory University School of Medicine, Grady Health System. All three hosts are also National HIV Curriculum Associate Editors.
The production of this National HIV Curriculum podcast was supported by Grant U10HA32104 from the Health Resources and Services Administration (HRSA) of the U.S. Department of Health and Human Services (HHS). Its contents are solely the responsibility of the University of Washington Infectious Diseases Education & Assessment (IDEA) Program and do not necessarily represent the official views of HRSA or HHS. Learn more at www.hiv.uw.edu/podcast.
Episodes
30 episodes
The BEe-HIVe Study: Major Findings from Two Publications
This episode reviews two recent papers on the practice-changing BEe-HIVe study, which assessed efficacy of a relatively new hepatitis B vaccine (known as HepB-CpG, or trade name Heplisav-B) for persons with HIV, and the resulting clini...
•
Season 2
•
Episode 9
•
24:30
Hepatitis C and HIV Coinfection: Diagnosis and Management
National HIV Curriculum Podcast Editors Dr. Jehan Budak and Dr. Aley Kalapila discuss the diagnosis and management of hepatitis C co-infection in persons with HIV, including direct acting antiviral (DAA) therapy, use of the simplified treatment...
•
Season 2
•
Episode 8
•
25:10
PML: Evaluation and Management
National HIV Curriculum Podcast Editors Dr. Jehan Budak and Dr. Aley Kalapila discuss their approach to diagnosing and managing Progressive Multifocal Leukoencephalopathy (PML) in a person with advanced HIV. View episode transcript at
•
Season 2
•
Episode 7
•
17:29
Integrating Injectable ART into Clinical Practice
Long-acting injectable ART (LAI) was not initially considered to be a treatment option for individuals with substantial barriers to taking oral ART. However, our understanding has evolved due to the experience of several clinics around the coun...
•
Season 2
•
Episode 6
•
41:36
Initial Laboratory Evaluation of a Person with HIV
National HIV Curriculum Podcast Editors Dr. Jehan Budak and Dr. Aley Kalapila discuss their approach to the initial laboratory evaluation with a person newly diagnosed with HIV, including HIV-specific, co-infection screening, and healthcare mai...
•
Season 2
•
Episode 5
•
17:44
CROI 2025: Four More Potentially Practice-Changing Abstracts
Dr. Jehan Budak and Dr. Raaka Kumbhakar, University of Washington Assistant Professors of Medicine, discuss CROI 2025 abstracts on the complexities of treating TB during pregnancy, the use of tenofovir alafenamide for people with TB, switching ...
•
Season 2
•
Episode 4
•
24:14
CROI 2025: CARES and BEeHIVe Studies and Their Potential Practice-Changing Impacts
What were the CROI 2025 major scientific research themes and the key findings from the CARES trial on long-acting injectable ART and the BEeHIVe study on hepatitis B vaccines for people with HIV? Drs. Jehan Budak and Raaka Kumbhakar, co-assista...
•
Season 2
•
Episode 3
•
23:32
Initial Visit & Evaluation for a Person with HIV
National HIV Curriculum Podcast editors Dr. Jehan Budak and Dr. Aley Kalapila discuss their approaches and key questions they ask during an initial visit and evaluation with a person who’s new to their clinic. View episode transcript at
•
Season 2
•
Episode 2
•
17:05
LATITUDE Study: Interim Findings and Implications
Dr. Aadia Rana, University of Alabama Birmingham Professor of Medicine and LATITUDE Study Chair, discusses the LATITUDE Study’s key findings to date and considerations for prescribing long-acting ART for individuals who struggle to take oral me...
•
Season 2
•
Episode 1
•
47:44
Implementation of the New HHS Anal Cancer Screening Guidelines
Dr. Jeff Schouten, UW faculty in Surgery and in Allergy and Infectious Diseases as well as ANCHOR trial co-investigator, discusses the new anal cancer screening guidelines for persons with HIV then focuses on implementation barriers and conside...
•
Season 1
•
Episode 17
•
40:38
The ANCHOR Study: Does Treatment of Anal HSIL Prevent Anal Cancer?
This episode reviews a landmark study published in 2022 that aimed to answer the question of whether treating anal high-grade squamous intraepithelial lesions (HSIL) prevents anal cancer for persons with HIV, a question that was previously unan...
•
Season 1
•
Episode 15
•
16:13
The SLIM LIVER Study: Use of Semaglutide for Persons with HIV
This episode reviews literature about the recent SLIM LIVER study which evaluated the impact of semaglutide, a GLP-1 receptor agonist, on persons with HIV and discusses the important implications on clinical practice. View episode transcript, l...
•
Season 1
•
Episode 12
•
23:52
Neurosyphilis: Evaluation and Management
National HIV Curriculum Podcast Editors Dr. Jehan Budak and Dr. Aley Kalapila discuss their approach to diagnosing and treating neurosyphilis in a person with HIV, including clinical manifestations, diagnostics, treatment, and therapeutic monit...
•
Season 1
•
Episode 21
•
22:31
Switching ART Regimens: A Discussion
The three National HIV Curriculum Podcast editors discuss the multiple factors they consider before switching to another oral ART option or to injectable cabotegravir/rilpivirine, including adherence, patient preference, weight gain, NRTI resis...
•
Season 1
•
Episode 20
•
35:59
Disseminated MAC: Evaluation and Management
National HIV Curriculum Podcast Editors Dr. Jehan Budak and Dr. Aley Kalapila discuss their approach to diagnosing and treating disseminated Mycobacterium avium complex in a person with advanced HIV, including prophylaxis and management of the ...
•
Season 1
•
Episode 19
•
23:20
Initial ART Regimens Considerations: A Discussion
The three National HIV Curriculum Podcast editors share their perspectives on recent guideline changes to initial ART choices for treatment-naïve individuals with HIV, practical considerations for first line and alternate ART regimens, and the ...
•
Season 1
•
Episode 18
•
23:43
Pneumocystis Pneumonia: Management
National HIV Curriculum Podcast Editors Dr. Jehan Budak and Dr. Aley Kalapila discuss their approach to treating Pneumocystis Pneumonia (PCP or PJP) in a person with advanced HIV, including the use of antimicrobials, adjunctive steroids, and wh...
•
Season 1
•
Episode 16
•
17:16
Evaluation of Dyspnea in a Person with Advanced HIV
Dyspnea in persons with advanced HIV has a broad differential diagnosis. National HIV Curriculum Podcast Editors Dr. Jehan Budak and Dr. Aley Kalapila discuss potential causes and diagnostic options with a specific focus on the wide array of di...
•
Season 1
•
Episode 14
•
26:39
Semaglutide Studies in PWH & What to Consider Before Prescribing
Dr. Kristine Erlandson, Associate Professor at the University of Colorado School of Medicine and SLIM LIVER study senior author, discusses recent key GLP-1 receptor agonist studies, clinical implications, and practical prescribing consideration...
•
Season 1
•
Episode 13
•
31:02
CMV Retinitis: Evaluation and Management
National HIV Curriculum Podcast Editors Dr. Jehan Budak and Dr. Aley Kalapila discuss possible causes of visual changes in advanced HIV and the diagnosis and management of CMV retinitis in people with HIV. View episode transcript at
•
Season 1
•
Episode 11
•
24:14
Should People with HIV Take Aspirin for CVD Prevention?
HIV exacerbates the risk for adverse cardiovascular events. Dr. Chris Longenecker, a University of Washington Associate Professor of Medicine, and National HIV Curriculum Podcast Lead Editor Dr. Brian Wood discuss the pros and cons around aspir...
•
Season 1
•
Episode 10
•
14:49
Toxoplasma Encephalitis: Management
National HIV Curriculum Podcast Editors Dr. Jehan Budak and Dr. Aley Kalapila discuss the diagnosis and treatment of toxoplasma encephalitis, potential side effects, and when to start or restart HIV antiretroviral therapy. View episode transcri...
•
Season 1
•
Episode 9
•
17:48
Cardiovascular Side Effects of Antiretroviral Therapy
Dr. Chris Longenecker, a University of Washington Associate Professor of Medicine, discusses the cardiovascular side effects, including effects on lipids, of common antiretroviral therapy (ART) drugs with National HIV Curriculum Podcast Lead Ed...
•
Season 1
•
Episode 8
•
20:03
Evaluation of Focal Neurological Symptoms in a Patient with Advanced HIV
National HIV Curriculum Podcast Editors Dr. Jehan Budak and Dr. Aley Kalapila discuss an approach to working up a patient with a CD4 <100 who presented with focal neurological deficits and abnormal brain imaging. View episode transcript at <...
•
Season 1
•
Episode 7
•
13:17
New Guidelines: Statin Therapy for People with HIV to Prevent CVD
The first ever statin therapy guidelines to prevent cardiovascular disease (CVD) in people with HIV were released February 27, 2024. Dr. Chris Longenecker, a University of Washington Associate Professor of Medicine, and National HIV Curriculum ...
•
Season 1
•
Episode 6
•
22:54